MassMutual Private Wealth & Trust
FBIO icon

MassMutual Private Wealth & Trust’s Fortress Biotech FBIO Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-53
Closed -$2K – 1559
2021
Q4 		$2K Hold
53
– – ﹤0.01% 1092
2021
Q3 		$3K Buy
+53
New +$2.59K ﹤0.01% 975

Other funds holding FBIO

Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return

MassMutual Private Wealth & Trust's FBIO Position: Q1 2022 in Review

MassMutual Private Wealth & Trust sold out of Fortress Biotech (FBIO) in Q1 2022, closing a stake of 53 shares — an estimated $2K sold.

MassMutual Private Wealth & Trust first reported a position in FBIO in Q3 2021 and held it in 2 quarters. The position peaked at $3K in Q3 2021. 79 funds tracked by Wall St. Rank hold FBIO as of Q1 2022.

  • MassMutual Private Wealth & Trust reported no remaining Fortress Biotech position as of Q1 2022 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 53 Fortress Biotech shares in Q1 2022, an estimated $2K.
  • MassMutual Private Wealth & Trust first reported a position in Fortress Biotech in Q3 2021 and held it in 2 quarters.
  • MassMutual Private Wealth & Trust's Fortress Biotech position peaked at $3K in Q3 2021.
  • 79 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2022.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2022, filed 8 Apr 2022.